Estimation of HOMA-IR and Triglyceride-Glucose Index in Single Females with PCOS

Authors

DOI:

https://doi.org/10.24086/cuesj.v10n1y2026.pp18-23

Keywords:

Polycystic ovarian syndrome, homeostatic model assessment for insulin resistance, triglyceride-glucose index, insulin resistance

Abstract

This study aims to estimate insulin resistance (IR) in single females with polycystic ovarian syndrome. A cross-sectional study was designed to assess the insulin hormone, blood glucose level, IR biomarker, triglyceride-glucose index, serum high-density lipoprotein, and triglyceride. The present included 45 single female participants whom a specialist gynecologist had previously diagnosed. Statistically, Females following a healthy diet showed a non-significant decrease in homeostatic model assessment for IR (HOMA-IR) and a fasting glucose-to-insulin ratio when compared with non-dieters. Regarding the menstrual cycle, the triglyceride-glucose index (a measure of IR) was considerably higher in females with irregular menstrual cycles (P ≤ 0.05) than in those with regular cycles. A significant positive (direct) correlation was observed between HOMA-IR and the triglyceride-Glucose (TyG) index among single females. This study indicated a strong positive correlation between HOMA-IR and the Triglyceride-Glucose Index among single female patients. In conclusion, a balanced diet is crucial for mitigating IR in this condition. Unusual menstruation was closely linked to poor metabolic profiles, such as increased IR and dyslipidemia.

Downloads

Download data is not yet available.

Author Biographies

Zahraakhan M. Taher , Department of Biomedical Sciences, College of Applied Sciences, Cihan University - Erbil

 Zahraakhan Maaroof Taher is an Assistant Lecturer with a M.Sc. degree in Clinical Biochemistry, teaching in the department of Biomedical Sciences at Cihan University-Erbil, Kurdistan Region, F.R. Iraq. Her research interest is  Clinical Biochemistry.

Bakhtawar Z. Omer , Department of Biomedical Sciences, College of Applied Sciences, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq

Bakhtawar Ziad Omer is an assistant lecturer at the Department of Biomedical Sciences, College of Applied Sciences, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq. Her research interest is Biomedical science.

Zheyan T. Younis, Department of Basic Science, College of Dentistry, Hawler Medical University, Erbil, Kurdistan Region, Iraq

Zheyan Tahir Younis is an Assistant Lecturer holding an M.Sc. degree in Physiology and teaching in the Department of Basic Science, College of Dentistry, Hawler Medical University, Erbil, Kurdistan Region, F.R. Iraq. Her research interest is Basic Science and Dentistry.

Dunya A. Asaad, Department of Medical Biochemical Analysis, College of Health Technology, Cihan University–Erbil, Erbil, Kurdistan Region, Iraq

Dunya Abdulqader Asaad holds a Master’s degree in Medical Biochemistry and currently serves as a Laboratory Assistant in the Department of Medical Biochemical Analysis, College of Health Technology, Cihan University–Erbil, Erbil, Kurdistan Region, F.R. Iraq.

 

References

J. Dong and D. A. Rees. Polycystic ovary syndrome: Pathophysiology and therapeutic opportunities. BMJ Medicine, vol. 2, no. 1, p. e000548, 2023. DOI: https://doi.org/10.1136/bmjmed-2023-000548

2. J. Yang and C. Chen. Hormonal changes in PCOS. Journal of Endocrinology, vol. 261, no. 1, p. e230342, 2024. DOI: https://doi.org/10.1530/JOE-23-0342

3. S. Siddiqui, S. Mateen, R. Ahmad and S. Moin. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). Journal of Assisted Reproduction and Genetics, vol. 39, no. 11, pp. 2439-2473, 2022. DOI: https://doi.org/10.1007/s10815-022-02625-7

4. J. P. Christ and M. I. Cedars. Current guidelines for diagnosing PCOS. Diagnostics (Basel), vol. 13, no. 6, p. 1113, 2023. DOI: https://doi.org/10.3390/diagnostics13061113

5. A. Joshi. PCOS stratification for precision diagnostics and treatment. Frontiers in Cell and Developmental Biology, vol. 12, p. 1358755, 2024. DOI: https://doi.org/10.3389/fcell.2024.1358755

6. S. H. Lee, S. Y. Park and C. S. Choi. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes and Metabolism Journal, vol. 46, no. 1, pp. 15-37, 2022. DOI: https://doi.org/10.4093/dmj.2021.0280

7. L. Szablewski. Changes in cells associated with insulin resistance. International Journal of Molecular Sciences, vol. 25, no. 4, p. 2397, 2024. DOI: https://doi.org/10.3390/ijms25042397

8. H. Majid, Q. Masood and A. H. Khan. Homeostatic model assessment for insulin resistance (HOMA-IR): A better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome. Journal of the College of Physicians and Surgeons Pakistan, vol. 27, no. 3, pp. 123-126, 2017.

9. Y. Zheng, G. Yin, F. Chen, L. Lin and Y. Chen. Evaluation of triglyceride glucose index and homeostasis model of insulin resistance in patients with polycystic ovary syndrome. International Journal of Women’s Health, vol. 14, pp. 1821-1829, 2022. DOI: https://doi.org/10.2147/IJWH.S387942

10. D. Hiam. The Molecular Basis of Polycystic Ovary Syndrome: Genetics, Epigenetics, and Insulin Resistance, Victoria University, [Ph.D. Dissertation], 2018.

11. K. J. Chang, J. H. Chen and K. H. Chen. The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: A molecular and cellular review of the literature. International Journal of Molecular Sciences, vol. 25, no. 16, p. 9037, 2024. DOI: https://doi.org/10.3390/ijms25169037

12. Y. Tian, J. Li, S. Su, Y. Cao, Z. Wang, S. Zhao and H. Zhao. PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS. Frontiers in Endocrinology, vol. 11, p. 274, 2020. DOI: https://doi.org/10.3389/fendo.2020.00274

13. A. L. Williams-Montgomery. The art of phlebotomy: Why is the order of draw so important? Journal of Allied Health, vol. 53, no. 3, pp. e187-e189, 2024.

14. J. P. Verma. Data Analysis in Management with SPSS Software. Springer Science and Business Media, Berlin, 2012. DOI: https://doi.org/10.1007/978-81-322-0786-3

15. N. Salari, A. Nankali, A. Ghanbari, S. Jafarpour, H. Ghasemi, S. Dokaneheifard and M. Mohammadi. Global prevalence of polycystic ovary syndrome in women worldwide: A comprehensive systematic review and meta-analysis. Archives of Gynecology and Obstetrics, vol. 310. no. 3, pp. 1303-1314, 2024. DOI: https://doi.org/10.1007/s00404-024-07607-x

16. Y. Shang, H. Zhou, M. Hu and H. Feng. Effect of diet on insulin resistance in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 10, p. dgaa425, 2020. DOI: https://doi.org/10.1210/clinem/dgaa425

17. H. J. Teede, M. L. Misso, M. F. Costello, A. Dokras, J. Laven, L. Moran, T. Piltonen and R. J. Norman. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, vol. 33, no. 9, pp. 1602-1618, 2018.

18. M. Sharifi, A. Saber, J. Moludi, Y. Salimi and A. Jahan-Mihan. The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: A randomized controlled trial. Nutrition Journal, vol. 23, no. 1, p. 152, 2024. DOI: https://doi.org/10.1186/s12937-024-01056-7

19. H. Hooshmandi, A. Ghadiri-Anari, A. M. Ranjbar, H. Fallahzadeh, M. Hosseinzadeh and A. Nadjarzadeh. Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): A randomized, double-blind, placebo-controlled trial. Journal of Ovarian Research, vol. 17, no. 1, p. 157, 2024. DOI: https://doi.org/10.1186/s13048-024-01446-9

20. S. Kiconco, H. J. Teede, A. Earnest, D. Loxton and A. E. Joham. Menstrual cycle regularity as a predictor for heart disease and diabetes: Findings from a large population‐based longitudinal cohort study. Clinical Endocrinology, vol. 96, no. 4, pp. 605-616, 2022. DOI: https://doi.org/10.1111/cen.14640

21. V. Christodoulopoulou, E. Trakakis, V. Pergialiotis, M. Peppa, C. Chrelias, D. Kassanos and N. Papantoniou. Clinical and biochemical characteristics in PCOS women with menstrual abnormalities. Journal of Family and Reproductive Health, vol. 10, no. 4, pp. 184-190, 2016.

22. A. Ayar Madenli and G. Özer. Comparison of clinical andbiochemical parameters in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Journal of Controversies in Obstetrics and Gynecology and Pediatrics, vol. 1, no. 4, pp. 90-94, 2023. DOI: https://doi.org/10.51271/JCOGP-0020

23. B. M. Zamila, H. Banu, M. S. Morshed, S. Shah, A. Begum, T. Sultana, N. Akhtar, M. Fariduddin, A. A. Saleh and M. A. Hasanat. Manifestations of polycystic ovary syndrome are similar regardless of the degree of menstrual cycle variation. International Journal of Human and Health Sciences, vol. 6, pp. 96-103, 2022. DOI: https://doi.org/10.31344/ijhhs.v6i1.383

24. S. Kwon, A. Heo and S. Chun. Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome. Obstetrics and Gynecology Science, vol. 66, no. 4, pp. 307-315, 2023. DOI: https://doi.org/10.5468/ogs.23103

25. M. Aghil, R. El-Megrabi, H. Alfaghi and R. Alrakhees. The relationship between insulin resistance and polycystic ovary syndrome in Libyan women. Khalij-Libya Journal of Dental and Medical Research, vol. 9, pp. 159-164, 2025. DOI: https://doi.org/10.47705/kjdmr.259203

26. A. Mansour, M. Mirahmad, M. R. Mohajeri-Tehrani, M. Jamalizadeh, S. Hosseinimousa, F. Rashidi, P. Asili and S. M. Sajjadi-Jazi. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population. Scientific Reports, vol. 13, no. 1, p. 10269, 2023. DOI: https://doi.org/10.1038/s41598-023-37513-2

27. E. Uysal, O. Tammo, E. Soylemez, M. Incebıyık, D. Filiz and M. Alci. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome. BMC Endocrine Disorders, vol. 24, no. 1, p. 160, 2024. DOI: https://doi.org/10.1186/s12902-024-01701-6

28. A. Javidan, A. Azarboo, S. Jalali, P. Fallahtafti, S. Moayyed, M. Ghaemi, A. Tarafdari and S. Hantoushzade. The association between triglyceride-glucose index and polycystic ovary syndrome: A systematic review and meta-analysis across different populations. Journal of Ovarian Research, vol. 18, no. 1, p. 163, 2025. DOI: https://doi.org/10.1186/s13048-025-01717-z

Published

2026-02-01

How to Cite

1.
Taher ZM, Omer BZ, Younis ZT, Asaad DA. Estimation of HOMA-IR and Triglyceride-Glucose Index in Single Females with PCOS. Cihan U Erbil SCI J [Internet]. 2026 Feb. 1 [cited 2026 Jun. 23];10(1):18-23. Available from: https://journals.cihanuniversity.edu.iq/index.php/cuesj/article/view/1614

Issue

Section

Research Article

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.